DUBLIN (AP) _ Allergan PLC (AGN) on Tuesday reported a loss of $786.8 million in its third quarter.
The Dublin-based company said it had a loss of $2.40 per share. Earnings, adjusted for one-time gains and costs, were $4.25 per share.
The results matched Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was also for earnings of $4.25 per share.
The Botox maker posted revenue of $4.05 billion in the period, surpassing Street forecasts. Six analysts surveyed by Zacks expected $3.89 billion.
Allergan expects full-year revenue in the range of $15.63 billion to $15.83 billion.
Allergan shares have increased 34% since the beginning of the year, while the Standard & Poor's 500 index has risen 23%. The stock has climbed nearly 10% in the last 12 months.